Corticosteroids during treatment with nivolumab may not affect survival in kidney cancer
A recent study published in the journal JAMA Oncology has [...]
Stopping smoking after kidney cancer diagnosis may reduce the risk of cancer progression and death
A recent study looked at whether stopping smoking after a [...]
Psychological distress in patients treated for kidney cancer
This review of the literature looked at how common psychological [...]
BMI and outcomes in patients with metastatic kidney cancer treated with first-line TKIs
This study looked at whether high or low body mass [...]
Survival after second-line therapy in patients with metastatic kidney cancer treated with first-line immunotherapy combinations
This study looked at real world information from patients with [...]
Ipilimumab-nivolumab and axitinib-pembrolizumab combinations produce similar survival times
When ipilimumab plus nivolumab or axitinib plus pembrolizumab are used [...]
Nivolumab compared to cabozantinib as a second- or third-line treatment
This study looked at real world data from people with [...]
Kidney cancer patient summit on immunotherapy/TKI combinations
The following presentations from the Educated Patient® Kidney Cancer Summit [...]
Biomarker for predicting disease recurrence in non-metastatic papillary kidney cancer
A biomarker is a biological molecule found in blood, other [...]
Outcomes of patients who stopped immunotherapy due to immune-related side effects
Immunotherapy has changed the way advanced renal cell carcinoma (RCC) [...]
